Skip to main content
SpringerLink
Log in

Azithromycin/favipiravir/hydroxychloroquine interactions

Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Cerik IB, et al. Impact of Adding Favipiravir to Hydroxychloroquine and Azithromycin Treatment on QTc Interval in COVID-19. Turkiye Klinikleri Cardiovascular Sciences 33: 15-21, No. 1, 2021. Available from: URL: http://doi.org/10.5336/cardiosci.2020-80082

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Azithromycin/favipiravir/hydroxychloroquine interactions. Reactions Weekly 1886, 89 (2021). https://doi.org/10.1007/s40278-021-07354-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-07354-3

Search

Navigation